Official UK procurement notice
Halton Place - Care at the Chemist & On Demand Access to Palliative Care Medicines
Authority: NHS Cheshire and Merseyside Integrated Care Board (Central government)
What is being bought
Published requirement description(CATC) The contracted pharmacy will provide advice and support to people on the management of minor ailments from the agreed formulary, including where necessary, the supply of medicines
for the treatment of the minor ailment, for those people who would have otherwise gone to their GP for a prescription.
Where appropriate the pharmacy may sell OTC medicines to the person to help manage the minor ailment, as described in the Community Pharmacy Contractual Framework, Essential Service- Support for Self-Care.
The pharmacy will operate a triage system, including referral to other health and social care professionals, where appropriate.
(ODAP) Community Pharmacies participating in this service will hold and maintain an agreed stock of medication for the ODAP service that they are commissioned to deliver. Patients entering the dying phase of a terminal illness often experience new or worsening symptoms including, pain, nausea, vomiting, agitation, increased respiratory tract secretions and dyspnoea. Prompt access via this service to medication to alleviate these symptoms is essential to avoid distress to both patients and their carers
and supports the patient's choice to die in their preferred place of care.
CPV: Health services
The lotProcurement structure
single lot · no lot value publishedLot #1NHS Cheshire and Merseyside ICB has awarded a one year contract via Direct Award A to…Awarded
NHS Cheshire and Merseyside ICB has awarded a one year contract via Direct Award A to selected Halton pharmacies across Cheshire and Merseyside. The contract commenced on 1st April
2025 and will expire on the 31st March 2026.
A fee of £2.00 will be paid for each consultation undertaken as part of the service.
A fee of £0.95 will be paid for each item dispensed as part of the service.
The Pharmacy will be reimbursed for the medication supplied under the 'CATC' service according to the current dm+d price.
Where patients are not exempt from prescription charges and have paid the NHS Levy to the Pharmacy, such sums will be deducted from the relevant month's remuneration.
ODAP - an annual retention fee of £1000 as well as remuneration for medicines.
The contract value is approximately £5160 and is
subject to change due to being an activity based contract. Funding is based on delivery of the activity outlined within the service specification.
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Award procedure without prior publication of a call for competition
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Services
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Unspecified in notice
- Recurring procurement
- Unspecified in notice
- First published
- 30 Apr 2025, 18:52 BST
- Last source update
- 30 Apr 2025, 18:52 BST
- Authority reference
25-26-QYG-01F-CATC/ODAP- FTS notice number
2025/S 000-018205- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-050ad0Find a Tender
- Why no open competition
- The procurement falls outside the scope of application of the directive
- Published justification
This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award.
Publisher note: This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. On the 19th of November 2024 the Finance, Investment, Resources Committee approved this decision. One committee member has a standing declaration of interest. The decision to award was made in line with the Conflict of Interest policy.
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| Strachan's Chemist | £2,580 † | — | Awarded |
| Gorgemead Ltd | £2,580 † | — | Awarded |
Contracts
Halton Place - Care at the Chemist & On Demand Access to Palliative Care Medicines · Strachan's Chemist
- Signed
- 19 Nov 2024
- Value
- £2,580
- Status
- active
Contract 018205-2025-25-26-QYG-01F-CATC/ODAP-2 · Gorgemead Ltd
- Signed
- 19 Nov 2024
- Value
- £2,580
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 1bids | — | — | — |
Contracting authority & participating public bodies
Bidders & participating suppliers
2 commercial parties on the notice- Cooke's Healthcare Ltd (Widnes Late Night Pharmacy)Awarded supplier
- PCT Healthcare Ltd (Peak Pharmacy)Awarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.